Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Evaluation of the Organization of Continuity of Care for Home Hospice Patients by Four Parisian Health Networks (DICODOM)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03336489
Recruitment Status : Completed
First Posted : November 8, 2017
Last Update Posted : December 7, 2018
Sponsor:
Information provided by (Responsible Party):
Fondation Ophtalmologique Adolphe de Rothschild

Brief Summary:

In Paris, France, home hospice care for terminally ill patients is organized by four "palliative care networks". These networks are responsible for information sharing and coordination of all health care professionals working with the patient. Two different systems are in place to ensure continuity of care outside working hours, in such a setting. In the first system, palliative care specialists from the network are reachable over the phone 24/7 by the patient or its caregivers, whenever needed. In the second system, medical information about the patient, regularly updated by the network's medical team, is available to professionals via a secure website, so that in case the patient requires an urgent medical home visit outside working hours, the visiting physician has access to accurate information.

The study's goal is to compare patient's and caregiver's satisfaction between these two systems of continuity of care.

For that purpose, patients will be taken care of as usual by every palliative care network. In every instance where the patient or caregivers have reached out for medical help through the network's continuity of care system, the patient or caregiver will be called 5 days later by the investigation team to go through a satisfaction questionnaire (Likert scales)


Condition or disease
Neoplasms Neurodegenerative Diseases Terminal Illness

Layout table for study information
Study Type : Observational
Actual Enrollment : 200 participants
Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Evaluation of the Organization of Continuity of Care for Home Hospice Patients by Four Parisian Health Networks
Actual Study Start Date : March 29, 2017
Actual Primary Completion Date : June 20, 2018
Actual Study Completion Date : November 7, 2018

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Hospice Care




Primary Outcome Measures :
  1. Satisfaction about the response given by the network's continuity of care system [ Time Frame: between the first and tenth day after the patient or caregiver activated the network's continuity of care system ]
    Patient's (or caregiver's) satisfaction about the response given by the network's continuity of care system, after the patient or caregiver activated this system at night time or during week-ends or bank holliday, as measured on a 4-level Likert scale (verbal questionnaire by phone call)



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
All patients newly followed for home hospice care by the four palliative care networks of Paris, France, during the inclusion period (up to the inclusion of 200 patients)
Criteria

Inclusion Criteria:

  • Patient has a disease with fatal prognosis and requires palliative care
  • Patient lives in Paris, France
  • Patient benefits from home hospice care through one of the four official Paris palliative care networks

Exclusion Criteria:

  • Pregnant women
  • Breastfeeding womed
  • Altered cognitive function with a Mini Mental Status below 20
  • Patient not able to communicate or not speaking French
  • Patient legally not capable of giving informed consent

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03336489


Locations
Layout table for location information
France
Reseau QUIETUDE
Paris, France, 75003
Reseaux ROPE
Paris, France, 75012
Reseau ENSEMBLE
Paris, France, 75013
Reseaux ParisOuest
Paris, France, 75015
Sponsors and Collaborators
Fondation Ophtalmologique Adolphe de Rothschild
Investigators
Layout table for investigator information
Principal Investigator: Herve PICARD, MD MSc Clinical Research Department, Rothschild Foundation, Paris (France)

Layout table for additonal information
Responsible Party: Fondation Ophtalmologique Adolphe de Rothschild
ClinicalTrials.gov Identifier: NCT03336489    
Other Study ID Numbers: HPD_2016_24
First Posted: November 8, 2017    Key Record Dates
Last Update Posted: December 7, 2018
Last Verified: November 2017

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Neurodegenerative Diseases
Nervous System Diseases